Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

91

P1037 Interaction of S100A13 With Vimentin in Pulmonary Fibrosis/ V.V. Raveendran, Riyadh, Saudi Arabia P1038 Oncostatin M, A Key Player in Fibrosis/ V. Kumar, Gaithersburg, MD

P1021 Mesenchymal Stem Cell-derived Humoral Factor STC-1 Suppresses Il-6 Auto-amplification in Bleomycin-induced Pulmonary Fibrosis Model/ S. Ohkouchi, Sendai, Japan P1022 Involvement of Ten-eleven Translocation Gene in the Pathology of Pulmonary Fibrosis/ K. Takagi, Kagoshima, Japan P1023 UPARAP: What Is It Doing in the Lung?/ B. Simon, Madison, WI P1024 Role of ALDH2 in Fibroproliferation After Acute Lung Injury/ Y. Aschner, Aurora, CO P1025 Characterization Of The Pericyte Transcriptome In Systemic Sclerosis-associated Interstitial Lung Disease/ C.L. Wilson, Madison, WI P1026 Skin Transcriptomes Are Associated With Lung Function Impairment in Systemic Sclerosis Related Interstitial Lung Disease/ J. Zielonka, New Haven, CT P1027 The Relationship Between MicroRNA Expression Profiles in Animal Models for Lung Fibrosis and Idiopathic Pulmonary Fibrosis/ K.U.E. Perera, Melbourne, Australia P1028 Online Cell Atlases Improve Interrogation of Lung Transcriptomic Data/ J. Flint, New Haven, CT P1029 A Multi-omics Approach Identifies That Human R Antigen (HuR) Controls Multiple Cellular Pathways in Idiopathic Pulmonary Fibrosis (IPF) Pathogenesis/ Q.S. Islam, Montreal, Canada P1030 Characterization of an Inducible Tensin1 Deficient Transgenic Murine Model by RNA Sequencing Analysis/ K. Holbert, Madison, WI P1031 G-Protein Coupled Receptor-Mediated Camp Activation Within Lung Fibroblasts Is Essential for Spontaneous Fibrosis Resolution Following Bleomycin-Induced Lung Injury/ S.M. Fortier, Ann Arbor, MI P1032 In Vivo Intra-airway Epigenetic Editing in the Promoter of CXCL11/ A.V. Fedulov, Providence, RI P1033 Oxidative Processes in the Endoplasmic Reticulum Contribute to Enhanced Oxidation of Collagen 1 and Promote Aberrant Activation of Lung Fibroblasts/ Y.M.W. Janssen-Heininger, Burlington, VT P1034 Mitogen Activated Protein Kinase Phosphatase 1 Induction Leads to P38 Inhibition and Myofibroblast De-differentiation/ N.M. Walker, Ann Arbor, MI P1035 Role of Myocardin on the Expression of Fibronectin 1 in Human Pleural Mesothelial Cells/ T. Sakai, Tyler, TX P1036 S100A3 Regulates the Expression of Telomerase Reverse Transcriptase (TERT)/ S. Al Qattan, Riyadh, Saudi Arabia

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A67

BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area J, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P1040 The Pulmonary Fibrosis Drug Connectome/ J. Flint, New Haven, CT P1041 The Therapeutic Gap in Idiopathic Pulmonary Fibrosis: Insights From Single Cell Transcriptional Profiling/ N. Mckenna, Houston, TX P1042 Functional Roles for CD26/DPP4 in Mouse Bleomycin-induced Pulmonary Fibrosis/ K. Yu, Chiba, Japan P1043 Inhaled Therapeutic for Idiopathic Pulmonary Fibrosis Reduces Fibrotic Biomarkers in Mouse Model/ A. Chang, Provo, UT P1044 Lactobacillus Based Live Biotherapeutic Product Downregulates Profibrotic Markers in Models of Pulmonary Fibrosis/ C.V. Lal, Birmingham, AL P1045 Combining Dual an ß6/ an ß1 Integrin Inhibitor, PLN-74809, With Standard-of-Care Therapies Has a Synergistic Effect on Reducing Fibrogenic Gene Expression in Fibrotic Human Lung Slices/ J. Schaub, South San Francisco, CA P1046 Lead Compound Development of Antifibrotic N23Ps and Molecular Target Identification/ X. Wei, Munich, Germany P1047 Anti-fibrotic Loaded Drug Delivery Vesicles Survive in Surfactant, Dramatically Improve Lung Pharmacokinetics, and Reach Multiple Alveolar Cell Types/ L. Ferguson, Philadelphia, PA P1048 Serum Collagen Neoepitopes Are Associated With

Multi-organ Disease in the Access and GRADS Sarcoidosis Cohorts/ C. Ryu, New Haven, CT

ATS 2023 • Washington, DC